Supplements

European Parliament hosts botanicals workshop

SME concerns raised at European Parliament botanicals workshop

By Shane STARLING

More than 70 stakeholders attended a botanicals workshop in the European Parliament’s Brussels offices last week as the heat increases to resolve regulatory ambiguity across the EU for herbal products - especially that ambiguity's impact on SMEs.

Roquette outsources lab to food supplements makers

Roquette outsources lab to food supplements makers

By Shane STARLING

French supplier Roquette is putting its R&D supplements facility up for rent by any party seeking to develop food supplements and food products – whether they are its own customers or not.

Faking it: Superfruit market 'ripe' for adulteration

Special edition: Superfruits - old news or still super?

Faking it: Superfruit market 'ripe' for adulteration

By Nathan Gray

Increasing raw material costs coupled with growing demand for natural health solutions has seen the market for superfruits boom in recent years, but has it may have also left the market ripe for adulteration.

Food Supplements Europe: A small industry needs to be united

Food Supplements Europe: A small industry needs to be united

By Shane Starling

Europe’s new multilateral food supplements group says there is no inherent conflict between its big player-small player membership as all share the same goal of amending scientific requirements under the EU’s strict new health claim rules.

CRN, Merck, DSM, BASF spark new EU food supplements group

CRN, Merck, DSM, BASF spark new EU food supplements group

By Shane STARLING

Better dialogue with regulators and scientists is the main purpose of a new European food supplements group formed today by a diverse alliance of national groups and ingredients and supplement players – both small and large.

Forté Pharma sales up 1.5% in 2012

Forté Pharma sales up 1.5% in 2012

By Shane Starling

2012 sales have risen 1.5% at Forté Pharma, the food supplements arm of Spanish player Natraceutical, with weight management products dominating.

GOED: Pharma is important for omega-3 but growing slowly

GOED: Pharma is important for omega-3 but growing slowly

By Shane Starling

Pharmaceutical omega-3 products are important but will grow more slowly than some expect because of the long timeframe for drug approval, says the chief of the Global Organisation for EPA and DHA Omega-3s (GOED).

How high can high-end omega-3 go?

Special edition: Omega-3 (Editor's blog)

How high can high-end omega-3 go?

By Shane STARLING

Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.

Cross-Atlantic choline team banks on EU health claim conversion

EU health claim winner

Cross-Atlantic choline team banks on EU health claim conversion

By Shane Starling

US supplier Balchem has joined with Dutch firm Van Eeghen Functional Ingredients (VEFI) to develop the European choline foods and food supplements market, after the nutrient won three EU health claims in 2012.

Isoflavone supplements may reduce breast cancer risk

Isoflavone supplements may reduce breast cancer risk

By Stephen DANIELLS

Women taking supplements containing isoflavones may have a lower risk of breast cancer, with high content supplements consistently linked with reduced risk, says a new analysis from Canada.

Follow us

Products

View more

Webinars